bpc 157 time frame Peptide BPC-157 Musculoskeletal and Tissue Healing with
Description
This is based on its ability to counteract ketamine and MK-801, NMDA receptor antagonists that model negative-like schizophrenia symptoms in rodents
50.3 KB Views: 153
Affiliate Professor at UTEP
This study aimed to determine the safety and pharmacokinetic prole of the BPC 157 peptide (NCT02637284) [ 105 ]
